KalVista Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
08 Oct 2025	Form 3: Arif Bilal, Chief Operations Officer No securities owned
02 Oct 2025	Form 3: Sensenig Bethany, Director No securities owned
25 Aug 2025	Form 3: Sweeny Nicole, Chief Commercial Officer
03 Feb 2025	Form 3: Venrock Healthcare Capital Partners III, L.p., 10% owner and 6 others Holds 4,942,773 shares of Common Stock
26 Nov 2024	Form 3: Reid Laurence, Director No securities owned
11 Sep 2024	Form 3: Piekos Brian, Chief Financial Officer No securities owned
22 Apr 2024	Form 3: Fairey William, Director No securities owned
28 Dec 2023	Form 3: Venrock Healthcare Capital Partners III, L.p., 10% owner and 6 others Holds 3,573,714 shares of Common Stock
27 May 2022	Form 3: Treanor Patrick, Director No securities owned
04 May 2021	Form 3: Audhya Paul K., Chief Medical Officer No securities owned
19 Mar 2021	Form 3: Stuart Nancy, Director No securities owned
28 Jun 2019	Form 3: Edwards Martin, Director Holds 0 shares of No Securities are beneficially owned
05 Jun 2019	Form 3: Smith Michael David, Sr. VP, Development
23 Apr 2019	Form 3: Soland Daniel B, Director Holds 0 shares of No Securities are beneficially owned
05 Feb 2019	Form 3: Pereira Brian Jg, Director Holds 0 shares of No Securities are beneficially owned
10 Sep 2018	Form 3: Venrock Healthcare Capital Partners II, L.p., 10% owner and 7 others Holds 2,044,112 shares of Common Stock
09 Mar 2017	Form 3: Maetzel Andreas, Senior Vice President Medical No securities owned
30 Nov 2016	Form 3: Feener Edward P., Chief Scientific Officer Holds 98,034 shares of Common Stock
30 Nov 2016	Form 3: Novo A/S, 10% owner Holds 2,901,927 shares of Common Stock
29 Nov 2016	Form 3: Resnick Joshua, Director No securities owned

Comments